Home Icon

Loading, Please Wait...

CST: 03/03/2021 12:18:12   

Deadline in Lawsuit for Investors in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced by Shareholders Foundation

729 Days ago

SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).

Investors, who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), have certain options and for certain investors are short and strict deadlines running. Deadline: April 1, 2019. NASDAQ: LXRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. 

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the data from Lexicon’s Phase 3 clinical trials assessing the safety and efficacy of Sotagliflozin in treating type 1 diabetes were not as positive as Lexicon represented, that the health risks posed by Sotagliflozin were severe enough to threaten its FDA approval prospects, and that as a result, Lexicon’s public statements were materially false and misleading at all relevant times.  

Those who purchased Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares should contact the Shareholders Foundation, Inc. 

Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108 

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.  

We Are Diffrent
Is your business listed correctly on America’s largest city directory network of 1,000 portals?